| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsored by: |
Shaheed Beheshti Medical University |
| Information provided by: | Shaheed Beheshti Medical University |
| ClinicalTrials.gov Identifier: | NCT00388778 |
Purpose
The purpose of this study is to compare the safety and efficacy of twice daily subantimicrobial dose doxycycline 20mg with daily doxycycline 100mg in treatment of mild and moderate Acne.
| Condition | Intervention | Phase |
|
Acne Inflammation |
Drug: Doxycycline |
Phase II Phase III |
| MedlinePlus related topics: | Acne |
| Drug Information available for: | Doxycycline Doxycycline calcium Doxycycline hyclate |
| Study Type: | Interventional |
| Study Design: | Treatment, Randomized, Double-Blind, Dose Comparison, Parallel Assignment, Safety/Efficacy Study |
| Official Title: | The Effect of Doxycycline 100mg and Doxycycline 20mg in Treatment of Mild and Moderate Acne |
Eligibility
| Ages Eligible for Study: | 18 Years to 40 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations| Contact: Parviz Toossi, M.D. | 98-21-22744392 | src@sbmu.ac.ir |
| Iran, Islamic Republic of | |||||
| Skin Research Center, Shaheed Beheshti Medical University | Recruiting | ||||
| Tehran, Iran, Islamic Republic of, 19899 | |||||
| Contact: Parviz Toossi, M.D. 98-21-22744392 src@sbmu.ac.ir | |||||
| Principal Investigator: Parviz Toossi, M.D. | |||||
| Sub-Investigator: Nahid Mohtasham, MD | |||||
| Shaheed Beheshti Medical University |
| Principal Investigator: | Parviz Toossi, M.D. | Shaheed Beheshti Medical University |
More Information
| Study ID Numbers: | src-pts-964 |
| First Received: | October 16, 2006 |
| Last Updated: | January 22, 2008 |
| ClinicalTrials.gov Identifier: | NCT00388778 |
| Health Authority: | Iran: Ethics Committee |
|
|
|
|
|
